Meet 40 German companies
June 19 – 22, 2017
San Diego Convention Center
San Diego, USA
Germany is one of Europe`s most important players in the field of biotechnology.
At BIO 2017 in San Diego around 50 German companies and institutions will present themselves with their ambitious product developments and services in the 20th German official presentation at BIO annual convention. These companies and institutions are convinced that their products and ideas will be received with great interest.
The German Federal Ministry for Economic Affairs and Energy (BMWi), the AUMA_Association of the German Trade Industry, German Association of Biotechnology Industries of the German Chemical Industry Association (DIB) and the German Biotechnology-Industry-Organization BIO Deutschland welcome you to the official German Presentation at BIO 2017 in San Diego.
Integration Site Analysis of Viral Vectors via (nr)LAM-PCR
Booth number: 4607-7
Booth number: 4507-5
Genekam Biotechnologie AG
Genekam Magnetic Beads
Booth number: 4607-3
Fraunhofer Institute for Toxicology and Experimental Medicine ITEM
Booth number: 4607-5
Cfm Oskar Tropitzsch GmbH
Booth number: 4607-4
Health Economics & Outcomes Research Value demonstration Dossiers for early benefit assessment and clinical evaluation of drugs Health Technology Assessment (HTA) Market analysis Assessemnt of inpatient and ambulatory sector potentials Competition and regulation an... | Further reading
DNA-Test for detection of influenza viruses H5N8 and H5N6.
Genekam Biotechnology AG has just developed two different kits for two different viruses, which are breaking out in many countries. H5N6 is infecting human beings also particularly a few cases are being reported in China and it may spread to our countries. H5N8 is breaking out in birds at presen... | Further reading
Linkers and Payloads for Antibody-Drug Conjugation (ADC)
We provide novel payloads with alternative mechanisms of action and innovative and patentable linkers. Besides the standard valine-citrulline type linkers, we can offer novel peptide based fragments, which serve as substrates to cathepsin B or in other type of enzymatic cleavage. Novel types l... | Further reading